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I. PROJECT ID NUMBER, PUBLICATION MORATORIUM INFORMATION, 
PROJECT DESCRIPTION: 
 
This manuscript is part of a pilot effort on the part of NIH staff and the Nature publishing 
group to provide a more convenient archive for "marker papers" to be published.  These 
"marker papers" are designed to provide the users of community resource data sets 
with information regarding the status and scope of individual community resource 
projects.  For further information see editorial in September 2010 edition of Nature 
Genetics (Nature Genetics, 42, 729 (2010)), and the Nature Precedings HMP summary 
page. 
 
Project IDs:  46877, 46311 
Publication moratorium: 12 months   
 
The vagina is an interactive interface between the host and the environment. Its surface 
is covered by a protective epithelium colonized by bacteria and other microorganisms. 
The ectocervix is nonsterile, whereas the endocervix and the upper genital tract are 
assumed to be sterile in healthy women. Therefore, the cervix serves a pivotal role as a 
gatekeeper to protect the upper genital tract from microbial invasion and subsequent 
reproductive pathology. Microorganisms that cross this barrier can cause preterm labor, 
pelvic inflammatory disease, and other gynecologic and reproductive disorders. 
Homeostasis of the microbiome in the vagina and ectocervix plays a paramount role in 
reproductive health. Depending on its composition, the microbiome may protect the 
vagina from infectious or non-infectious diseases, or it may enhance its susceptibility to 
them. Because of the nature of this organ, and the fact that it is continuously colonized 
by bacteria from birth to death, it is virtually certain that this rich environment evolved in 
concert with its microbial flora. Specific interactions dictated by the genetics of both the 
host and microbes are likely responsible for maintaining both the environment and the 
microbiome. However, the genetic basis of these interactions in both the host and the 
bacterial colonizers is currently unknown. Lactobacillus species are associated with 
vaginal health, but the role of these species in the maintenance of health is not yet well 
defined. Similarly, other species, including those representing minor components of the 
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overall flora, undoubtedly influence the ability of potential pathogens to thrive and cause 
disease. Gross alterations in the vaginal microbiome are frequently observed in women 
with bacterial vaginosis, but the exact etiology of this disorder is still unknown.  There 
are also implications for vaginal flora in non-infectious conditions such as pregnancy, 
pre-term labor and birth, and possibly fertility and other aspects of women’s health. 
Conversely, the role of environmental factors in the maintenance of a healthy vaginal 
microbiome is largely unknown. To explore these issues, we have proposed to address 
the following questions: 
 
1. Do the genes of the host contribute to the composition of the vaginal 
microbiome? We hypothesize that genes of both host and bacteria have 
important impacts on the vaginal microbiome. We are addressing this question 
by examining the vaginal microbiomes of mono- and dizygotic twin pairs selected 
from the over 170,000 twin pairs in the Mid-Atlantic Twin Registry (MATR). 
Subsequent studies, beyond the scope of the current project, may investigate 
which host genes impact the microbial flora and how they do so. 
2. What changes in the microbiome are associated with common non-
infectious pathological states of the host? We hypothesize that altered 
physiological (e.g., pregnancy) and pathologic (e.g., immune suppression) 
conditions, or environmental exposures (e.g., antibiotics) predictably alter the 
vaginal microbiome. Conversely, certain vaginal microbiome characteristics are 
thought to contribute to a woman’s risk for outcomes such as preterm delivery.  
We are addressing this question by recruiting study participants from the ~40,000 
annual clinical visits to women’s clinics of the VCU Health System. 
3. What changes in the vaginal microbiome are associated with relevant 
infectious diseases and conditions? We hypothesize that susceptibility to 
infectious disease (e.g. HPV, Chlamydia infection, vaginitis, vaginosis, etc.) is 
impacted by the vaginal microbiome. In turn, these infectious conditions clearly 
can affect the ability of other bacteria to colonize and cause pathology. Again, we 
are exploring these issues by recruiting participants from visitors to women’s 
clinics in the VCU Health System. 
 
Three kinds of sequence data are generated in this project: i) rDNA sequences from 
vaginal microbes; ii) whole metagenome shotgun sequences from vaginal samples; and 
iii) whole genome shotgun sequences of bacterial clones selected from vaginal 
samples. The study includes samples from three vaginal sites: mid-vaginal, cervical, 
and introital.  The data sets also include buccal and perianal samples from all twin 
participants. Samples from these additional sites are used to test the hypothesis of a 
per continuum spread of bacteria in relation to vaginal health. An extended set of clinical 
metadata associated with these sequences are deposited with dbGAP. We have 
currently collected over 4,400 samples from ~100 twins and over 450 clinical 
participants. We have analyzed and deposited data for 480 rDNA samples, eight whole 
metagenome shotgun samples, and over 50 complete bacterial genomes. These data 
are available to accredited investigators according to NIH and Human Microbiome 
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Project (HMP) guidelines. The bacterial clones are deposited in the Biodefense and 
Emerging Infections Research Resources Repository (http://www.beiresources.org/).  
 
In addition to the extensive sequence data obtained in this study, we are collecting 
metadata associated with each of the study participants. Thus, participants are asked to 
complete an extensive health history questionnaire at the time samples are collected. 
Selected clinical data associated with the visit are also obtained, and relevant 
information is collected from the medical records when available. This data is 
maintained securely in a HIPAA-compliant data system as required by VCU’s 
Institutional Review Board (IRB). The preponderance of these data (i.e., that judged 
appropriate by NIH staff and VCU’s IRB are deposited at dbGAP 
(http://www.ncbi.nlm.nih.gov/gap). Selected fields of this data have been identified by 
NIH staff as ‘too sensitive’ and are not available in dbGAP. Individuals requiring access 
to these data fields are asked to contact the PI of this project or NIH Program Staff.   
 
II. DATA QUALITY:  
 
Metagenomic 16S rDNA Sequencing. Our metagenomic rDNA sequences are 
generated from the PCR amplified V1-V3 (E. coli rDNA coordinates: 27-534) region of 
the bacterial small subunit rRNA gene from DNA isolated from swab samples taken 
from the mid-vaginal wall, cervix, introitus, perianum and buccal cavity of twin 
participants from the Mid-Atlantic Twin Registry, or from visitors to women’s clinics at 
the VCU Health Center. The amplified products are sequenced using Roche 454 
Titanium technology. The 16S rDNA post-sequencing analysis pipeline is designed to 
filter the reads based on quality, to trim the barcode (Multiplex Identifier) and PCR 
amplification primer sequences, and to assign taxonomy to the high quality reads 
obtained. Our analysis pipeline retains those reads for which: i) a valid PCR primer and 
barcode is detected; ii) less than 10% of base calls have a quality score below Q10 iii); 
average quality of the bases in the read exceeds Q20; and iv) the read includes more 
than 200 but less than 540 bases. Approximately 80% of the reads are retained after 
the application of these quality control metrics. These high quality reads are assigned 
taxonomy using the RDP Classifier (1) with a minimum bootstrap confidence of 80%. 
Additional analyses are also applied to specific subsets of reads to identify operational 
taxonomic units (OTUs).  
 
Whole Metagenome Shotgun Sequencing. Whole metagenome shotgun sequencing; 
i.e., shotgun sequencing of unamplified total DNA in a sample, is applied to selected 
vaginal samples from twin and clinical participants as described above. Reads for data 
that pass minimum quality standards for 454 Titanium sequencing are subjected to a 
preliminary screen (BLASTN with 1E-20 E-value cutoff and at least 90% sequence 
identity to the National Center for Biotechnology Information reference human genome 
build 37) to identify and filter reads from human DNA prior to submission to National 
Center for Biotechnology Information SRA Protected Database. Taxonomic content and 
metabolic potential of these samples is assessed as described below. 
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Bacterial Clone Sequencing. Bacteria of interest are cultured and colony cloned from 
vaginal samples showing distinctive microbiome profiles. DNA is isolated using standard 
laboratory protocols and submitted for sequencing on the Illumina GAIIX or Roche 454 
Titanium Sequencer. Sequences are assembled using Velvet (2), Newbler (Roche 
Diagnostics) or other appropriate assembler. Sequences of these bacterial clones will 
meet or exceed ‘Standard Draft’ quality as defined in Chain et al. (3). We have 
compared the complete genome sequences from a panel of Gardnerella vaginalis (4), 
Lactobacillus sp., Sneathia, and other isolates (in preparation), taken from our samples. 
 
III. DATA ANALYSIS AND PUBLICATION PLANS:   
 
Metagenomic 16S rDNA taxonomic analysis. The 16S rDNA reads are binned using 
both taxonomic approaches and operational taxonomic units (OTUs) as described 
above. These data are then analyzed using a variety of methods. First, an assessment 
of experimental variation through the analysis of technical replicates is conducted so 
that true differences in the samples can be correctly confirmed. We then use 
visualization techniques such as variations of principal component analysis (PCA) (4) 
and stacked bar plots to compare microbiome profiles in samples based on abundant 
taxa in samples. We are developing statistical techniques for confirming that groups of 
samples arise from different distributions. Machine learning techniques and techniques 
grounded in measurement theory are used to identify the organisms/functional groups in 
microbiome profiles that correlate with clinical metadata. Longitudinal analyses are also 
being conducted to assess effects of the time in cycle on the microbiome.  Experiments 
are planned to quantify any bias introduced in the 16S rDNA analysis pipeline. 
 
Analysis of whole metagenome shotgun sequence data. After removal of 
‘contaminating’ human sequence (see above), analysis of data from whole metagenome 
shotgun sequencing is performed in two different dimensions: taxonomic content and 
metabolic potential. Taxonomic content, which is intended to be compared to that 
derived from 16S studies, is analyzed by similarity searches (BLASTX [5], 1E-6 cutoff) 
of the filtered reads against the NR database at the National Center for Biotechnology 
Information, followed by analysis with MEGAN (6). Metabolic potential is being analyzed 
using ASGARD (7) in combination with UniProt (8) and KEGG (9) data to generate lists 
of functional entities and putatively present pathways, as well as graphical metabolic 
maps comparing different samples.  
 
Analysis of bacterial genome sequences. Interesting bacterial clones are sequenced 
and assembled as described above. Genes are called using a variety of gene calling 
packages. Metabolic reconstructions and genome comparisons are performed using 
ASGARD in combination with UniProt or KEGG data. Genomes are compared to 
existing reference genomes, when available, and to genomes of related bacterial 
isolated from relevant samples; e.g., mono- or dizygotic twins, microbiomes with 
unexpected or unusual profiles, etc. 
 
Twin Studies. The VCU twin microbiome study is targeting 250-350 pairs of adult female 
mono- and dizygotic twins ascertained through the population-based Mid-Atlantic Twin 
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Registry (“MATR”). This sample, unselected for clinical history, will be supplemented by 
twin pairs ascertained to enrich the representation of significant clinical outcomes. 
Microbial samples from multiple body sites are obtained and characterized for twin 
participants, supplemented by metadata gathered by supervised self-report 
questionnaire obtained at the time of clinic visit.  A variety of univariate and multivariate 
techniques for genetic analysis of twin data have been developed and will be applied to 
the microbial data to: i) estimate the contributions of genetic and environmental factors 
to differences in prevalence of individual taxa at specific sites; ii) identify clusters of 
bacterial taxa whose co-occurrence depends on shared genetic or environmental risk 
factors in the host; iii) test for genetic and environmental factors that have a general 
effect on the composition of the microbiome across different sites; iv) identify specific 
environmental factors in the metadata that account for non-genetic differences with 
monozygotic twin pairs; v) test for the interaction of genetic effects in the host with 
specific environmental exposure on aspects of the human microbiome (genotype-
environment interaction); vi) identify intermediate behavioral pathways (e.g. sexual 
behavior, substance use) that mediate the influence of the host genotype through 
differential exposure to environmental risk (genotype-environment correlation). 
 
Publication Plans. Consortium participants anticipate publication of papers describing 
the general approaches and methodology employed in this project, general data 
relevant to the specific aims of the project, and specific findings relevant to the specific 
milestones and objectives of the participants. Our analyses of these data will be 
published as soon as reasonably possible following its generation, in general, prior to 
the publication moratorium end dates. In some cases; e.g., variance components 
analysis of mono- and dizygotic twin data, analyses will be delayed until sufficient 
numbers of twin pairs have been recruited for the study. Thus, whereas preliminary data 
could be published with a suboptimal number of twin pairs, we will adopt a conservative 
approach to ensure that the conclusions are meaningful and valid. Therefore, to avoid 
compromising the final product and thus doing compromising the long term objectives of 
NIH in funding this project, we request that individuals planning to use our data in 
publications first consult with the PI of the project before beginning their analysis.  
 
IV. DATA RELEASE PLAN:   
 
The VCU Vaginal Microbiome Consortium ascribes to NIH standard data release 
polices for rapid release of sequencing data such as that generated in this project. The 
policies are summarized in several web sites; e.g., NIAID policy is found at: 
http://www3.niaid.nih.gov/research/resources/mscs/data.htm; General NIH guidelines: 
http://grants.nih.gov/grants/policy/data_sharing/; http://www.genome.gov/10506376. 
Metagenomic rDNA sequence and whole metagenome sequence data from vaginal 
samples, and whole genome shotgun data from selected bacterial clones will be 
deposited in the short read archives at National Center for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi). Metadata associated with these 
samples will be released to appropriate investigators through dbGAP 
(http://www.ncbi.nlm.nih.gov/gap). As described above, NIH has requested that certain 
particularly sensitive fields of the metadata not be released with the standard metadata 
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files. Individuals requiring access to these data are encouraged to contact NIH or the PI 
of the project.    
 
V. CONTACT PERSON:  
 
Dr. Gregory A. Buck, Virginia Commonwealth University, Richmond, Virginia; email: 
gabuck@vcu.edu; phone: (804) 828-2318. 
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